About ▼ Careers Internship MedBlog Contact us

LOGIN REGISTER

Advertisement

Medindia » Health Press Releases A-Z

SEATTLE GENETICS (SGEN) ALERT: Johnson & Weaver, LLP Announces Filing of Class Action Complaint Against Seattle Genetics, Inc.; Encourages all Investors to Contact the Firm for Information

Advertisement

Sponsored Post and Backlink Submission

Latest Press Release on Genetics & Stem Cells News

SCG Cell Therapy Presented New Preclinical Data in an Oral Presentation at ASGCT 2024 Annual Meeting Highlighting Superior Tumor Inhibition of its Immunoswitch Armored HPV-TCR T Cell Therapy (SCG142) against a Broad Range of HPV-associated Cancers

SINGAPORE , May 12, 2024 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing novel immunotherapies for infectious diseases and their ...

Medical College of Wisconsin Cancer Center leads groundbreaking change in Medicare policy for MDS patients over 65 in need of lifesaving transplants

MILWAUKEE , May 8, 2024 /PRNewswire/ -- The Centers for Medicare & Medicaid Services recently issued a decision to expand Medicare coverage for allogeneic hematopoietic stem cell ...

BioLineRx Announces Poster Presentation on Economic Model Data for APHEXDA® (motixafortide) as part of CD34+ Hematopoietic Stem Cell Mobilization in Patients with Multiple Myeloma at ISPOR 2024

- Presentation Today, Monday, May 6, 2024 in Atlanta , Georgia - TEL AVIV, Israel , May 6, 2024 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial s...

Early Check Newborn Screening Study Taps Revvity to Provide Genome Sequencing

The North Carolina -based study will continue to test enrolled newborns for hundreds of childhood-onset rare genetic conditions RESEARCH TRIANGLE PARK, N.C. and WALTHAM, Mass. ...

GeneVentiv Therapeutics Awarded $2.5 Million SBIR Grant to Advance Gene Therapy for All Hemophilias, with or without Inhibitors

Damon R. Race , President & CEO RALEIGH, N.C. , April 16, 2024 /PRNewswire/ -- GeneVentiv Therapeutics, developer of GENV-HEM (AAV8.FVa) for all hemophilias, announced to...

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use Ok, Got it. Close